IMGN Financial Facts
General and administrative: 9.46MResearch and development support: 1.35M
See Full Income Statement
Deferred revenue, net of current portion: 19.16M
Accrued compensation: 6.75M
See Full Balance Sheet
Immunogen Inc. (IMGN) Earnings
|
Expand Research on IMGN
Next EPS Date | 4/25/24 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
---|---|---|---|
Average EPS % Beat Rate | +73.5% | Revenue Growth Rate | -100.0% *Last Qtr. |
Average % Move 1-Wk after EPS | +51.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
2/9/24 | Q423 | N/A | $0.13 | N/A | N/A | $129.48M | N/A | N/A | N/A | ||
2/12/24 | Q423 | N/A | $0.13 | N/A | N/A | $129.48M | N/A | N/A | N/A | ||
11/2/23 | Q323 | $0.10 | $0.04 | +$0.06 | $113.4M | $103.68M | N/A | Details | |||
7/31/23 | Q223 | -$0.02 | -$0.13 | +$0.11 | $77.4M | $49.15M | N/A | Details | |||
4/28/23 | Q123 | -$0.16 | -$0.25 | +$0.09 | $49.9M | $20.97M | N/A | Details | |||
2/10/23 | Q422 | N/A | -$0.30 | N/A | N/A | $17.43M | = | N/A | N/A | ||
2/13/23 | Q422 | N/A | -$0.30 | N/A | N/A | $17.43M | = | N/A | N/A | ||
3/1/23 | Q422 | -$0.23 | -$0.30 | +$0.07 | $41.17M | $17.43M | N/A | Details |